MONIYOT-131 CAPSULES 37-7400MBq capsules for therapeutic use medication leaflet

V10XA01 sodium iodide (131I) • Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds

Natrii iodidum (131I) is a radioactive compound used in the treatment and diagnosis of thyroid conditions such as hyperthyroidism and thyroid cancer. It emits radiation that destroys overactive or cancerous thyroid cells.

It is administered orally, in capsule or solution form, and is quickly absorbed by the thyroid gland. Treatment with Natrii iodidum (131I) is effective and minimally invasive, serving as an alternative to surgical interventions.

Side effects may include dry mouth, fatigue, or inflammation of the salivary glands. As a radioactive compound, its use requires special precautions to minimize radiation exposure.

Consult your doctor to discuss the benefits and risks of treatment with Natrii iodidum (131I). It is important to follow all instructions to ensure the safety and effectiveness of the treatment.

General data about MONIYOT-131 CAPSULES 37-7400MBq

Substance: sodium iodide (131I)

Date of last drug list: 01-01-2019

Commercial code: W58677004

Concentration: 37-7400MBq

Pharmaceutical form: capsules for therapeutic use

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MONROL EUROPE S.R.L. - UNGARIA

Holder: MONROL EUROPE S.R.L. - ROMANIA

Number: 8894/2016/01

Shelf life: 30 days-after packing for marketing

Concentrations available for sodium iodide (131I)

0.333 MBq - 3.7 MBq, 0.37-3.7GBq, 0.37-36MBq, 14.8-3700MBq, 3.7MBq, 3.7MBq.1.85MBq.0.925MBq, 37-5500MBq, 37-7400MBq, 37MBq-5.55GBq, 38-7400MBq, 50- 7400MBq